Avidian Wealth Enterprises’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227K | Sell |
5,325
-450
| -8% | -$20.1K | 0.01% | 667 |
|
|
2026
Q1 | $278K | Sell |
5,775
-146
| -2% | -$6.81K | 0.01% | 555 |
|
|
2025
Q4 | $287K | Buy |
5,921
+31
| +0.5% | +$1.54K | 0.01% | 483 |
|
|
2025
Q3 | $278K | Buy |
5,890
+154
| +3% | +$7.43K | 0.01% | 484 |
|
|
2025
Q2 | $277K | Sell |
5,736
-17
| -0.3% | -$869 | 0.01% | 455 |
|
|
2025
Q1 | $319K | Buy |
5,753
+43
| +0.8% | +$2.33K | 0.01% | 405 |
|
|
2024
Q4 | $275K | Sell |
5,710
-30
| -0.5% | -$1.52K | 0.01% | 418 |
|
|
2024
Q3 | $331K | Sell |
5,740
-127
| -2% | -$6.86K | 0.02% | 380 |
|
|
2024
Q2 | $285K | Sell |
5,867
-3,189
| -35% | -$154K | 0.01% | 400 |
|
|
2024
Q1 | $440K | Sell |
9,056
-184
| -2% | -$8.98K | 0.02% | 284 |
|
|
2023
Q4 | $460K | Buy |
9,240
+330
| +4% | +$16.1K | 0.03% | 277 |
|
|
2023
Q3 | $478K | Sell |
8,910
-349
| -4% | -$18.6K | 0.03% | 265 |
|
|
2023
Q2 | $499K | Buy |
9,259
+450
| +5% | +$24.2K | 0.03% | 265 |
|
|
2023
Q1 | $479K | Hold |
8,809
| – | – | 0.03% | 302 |
|
|
2022
Q4 | $427K | Sell |
8,809
-130
| -1% | -$5.71K | 0.03% | 299 |
|
|
2022
Q3 | $340K | Sell |
8,939
-212
| -2% | -$9.45K | 0.02% | 301 |
|
|
2022
Q2 | $458K | Buy |
9,151
+128
| +1% | +$6.79K | 0.03% | 279 |
|
|
2022
Q1 | $463K | Sell |
9,023
-1,333
| -13% | -$68.8K | 0.03% | 314 |
|
|
2021
Q4 | $519K | Buy |
10,356
+1,625
| +19% | +$80.4K | 0.03% | 291 |
|
|
2021
Q3 | $421K | Buy |
8,731
+415
| +5% | +$21.1K | 0.03% | 240 |
|
|
2021
Q2 | $438K | Buy |
8,316
+37
| +0.4% | +$1.93K | 0.03% | 245 |
|
|
2021
Q1 | $409K | Sell |
8,279
-1,062
| -11% | -$51K | 0.03% | 240 |
|
|
2020
Q4 | $454K | Buy |
9,341
+246
| +3% | +$12.1K | 0.04% | 199 |
|
|
2020
Q3 | $456K | Buy |
9,095
+647
| +8% | +$33.3K | 0.05% | 169 |
|
|
2020
Q2 | $431K | Buy |
8,448
+640
| +8% | +$31.1K | 0.06% | 148 |
|
|
2020
Q1 | $341K | Sell |
7,808
-89
| -1% | -$4.26K | 0.05% | 134 |
|
|
2019
Q4 | $396K | Buy |
7,897
+406
| +5% | +$19K | 0.06% | 144 |
|
|
2019
Q3 | $347K | Buy |
7,491
+740
| +11% | +$31.9K | 0.06% | 134 |
|
|
2019
Q2 | $292K | Buy |
6,751
+1,548
| +30% | +$65.8K | 0.07% | 109 |
|
|
2019
Q1 | $230K | Buy |
+5,203
| New | +$223K | 0.05% | 113 |
|
|
2018
Q1 | – | Sell |
-1,372
| Closed | -$59M | – | 111 |
|
|
2017
Q4 | $59M | Buy |
+1,372
| New | +$63.3K | 15.78% | 1 |
|
Other funds holding SNY
MIP
BIP
Avidian Wealth Enterprises's SNY Position: Q2 2026 in Review
Avidian Wealth Enterprises reduced its Sanofi (SNY) stake by 7.8% in Q2 2026, selling an estimated $20.1K and leaving 5,325 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #667.
Avidian Wealth Enterprises first reported a position in SNY in Q4 2017 and has held it in 31 quarters since. The position peaked at $59M in Q4 2017. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.
- Avidian Wealth Enterprises held 5,325 shares of Sanofi worth $227K as of Q2 2026.
- Avidian Wealth Enterprises sold 450 Sanofi shares in Q2 2026, an estimated $20.1K.
- Sanofi made up 0.01% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #667 holding.
- Avidian Wealth Enterprises first reported a position in Sanofi in Q4 2017 and has held it in 31 quarters since.
- Avidian Wealth Enterprises's Sanofi position peaked at $59M in Q4 2017.
- 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.
Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.